GTCR exits Cord Blood Registry to AMAG Pharmaceuticals for $700m

GTCR, a Chicago-based private equity firm, is to sell Cord Blood Registry, a stem-cell storage company, to Massachusetts-based AMAG Pharmaceuticals for $700m.